CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

NEONSTONE has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 5 Clinical Trial Services Companies in UK – 2023,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with Gareth Hughes, Director .

NEONSTONE
A Customized, Digitalized Approach To Clinical Trial Support

NEONSTONE

Gareth Hughes, NEONSTONE | Life Science Review | Top Clinical Trial Services Companies in FranceGareth Hughes, Director
Each clinical trial initiates a chain reaction that catalyzes numerous groundbreaking medical advancements. These trials play a pivotal role in efficiently evaluating the efficacy and safety of medical devices, expediting treatments, and revolutionizing pharmaceuticals. However, the traditional paper-based, decentralized approach to trial management has posed challenges to operational efficiency, creating obstacles for research teams in their mission to develop innovative products for patient communities. It's clear that addressing the existing inefficiencies related to patient identification, recruitment, and data acquisition can help in optimizing trial costs and reducing the burden on participants, ultimately streamlining the already lengthy clinical trial timelines.

A digital transformation in clinical trial management presents itself as an ideal solution for the life science industry. It can offer the flexibility to enhance, automate, and centralize these vital clinical processes.

Neonstone can help make that transition.

A Leader in Clinical Trial Management

As a leading software development firm, Neonstone excels in providing clinical trials with a digital edge through its highly flexible and time-tested clinical trials management platform. Crafted by seasoned experts with a passion for optimizing clinical trials, it empowers professionals with improved referral tracking, site based protocol training and certification, resource management, and pre-screening capabilities, allowing clinical research organizations (CROs), pharmaceutical companies, and academic research institutions to streamline operations and dedicate more time to finalizing trials with its validated digital platform.

Each trial is a complex puzzle with numerous distinct pieces, making a one-size-fits-all approach inadequate for ensuring operational excellence. Clinical organizations need precisely customized solutions to reduce costs, reach diverse patient populations, monitor patient safety, and incorporate new and novel data sources into trials,” says Gareth Hughes, Director of Neonstone. “Our platform reduces project start-up time, simplifies requirements, and shortens the go-live time."

Customization: The Key to Success

Neonstone's competitive edge lies in its commitment to offering customized solutions in an era where cookie-cutter approaches are becoming prevalent in the clinical trial space. Embracing a modular approach to product development, its platform can be seamlessly customized with bespoke configurations and workflows at the global and project levels to meet each client's distinct requirements. The firm ensures it offers only the appropriate tools or modules needed to guide a project to success, without affecting other projects.

This ability stems from its deep understanding of clinical trials, honed over 13 years of industry experience. Neonstone boasts a track record of serving over 330 clinical trials in a wide range of therapeutic areas and collaborating with over 100,000 investigators. All of this makes it a perfect partner for numerous businesses, allowing them to keep pace with the digitalization of their clinical trials.

Patient and Site-Facing Solutions

Staying true to this mission, Neonstone has developed a platform that covers all aspects of a clinical trial. The Neonstone platform comes with a set of robust tools and modules that streamline the patient-facing side of operations. This Patient Connect solution features a patient referral management tool. It's a global, multilingual, public-facing website that delivers the highest levels of flexibility to ensure compliance in different markets. It acts as an online pre-screener that helps potential patients match with a site. The team works with clients to assist them in running efficient ad campaigns, referring patients to websites, and managing the referral processes. By completely digitalizing patient identification and recruitment, Neonstone helps widen their outreach to a more diverse population and enroll the best prospects in trials, which, in turn, widens the scope of the study while reducing overall costs.
Beyond recruitment, the Patient Connect module's real-time referral reporting allows clients to access referral funnels and seamlessly track user journeys from referral to enrollment. It also includes a patient website that allows enrolled patients to access and view information about the study, view their upcoming appointments, and information about their visits to ensure they are always prepared. This enables the clinical teams to ensure seamless patient engagement, which is complemented by its patient mobile application and SMS and email reminder tools.

A Central Hub for Clinical Trial Management

Another significant part of the platform is its Site Connect module, which features a suite of robust tools, bespoke configurations, and workflows to streamline the site-facing operations of clinical trials. Its workflow for communication is built to provide all stakeholders with the right avenues for facilitating seamless communication, be it on-site or with patients. This expertly fosters efficient engagement by ensuring actions and requirements are adequately conveyed with the appropriate escalation strategy.
Clients can use its pre-screen workflows to help determine potential eligibility and capture pre-screening activity on the study. The solution automatically generates the participant's visit schedule along with applicable visit windows, which is then quickly linked with the patient app to drive information to patients.

Its centralized data capture and real-time reporting workflows are ideal for gaining insights into compliance and study progress, reducing management hours, and drastically increasing visibility.

This is truly beneficial for large and geographically diverse studies, as this centralized approach to data management reduces error and process delays. By eliminating the need for manual interventions and automating various day-to-day mundane tasks, Neonstone's solution enhances clients' operational efficiency, proactively supporting study teams to do what they do best.

The system can send real-time alerts to all stakeholders on detecting any missed actions, delays, or errors, prompting the study teams to take necessary measures to avoid mishaps. This largely complements clients' excellence in navigating a project to success. Site Connect also features a document repository tool that helps clients store study-related documentation for easy access.

The Excellence of Client-Centricity

“While we're a software development firm, we're not software-first. Rather, we embrace a true customer-centric approach to understand the problems and needs and then develop solutions tailored to their culture and business model,” says Hughes.

Our Platform Helps Reduce Start-Up Time For A Project, Reduces Complexity In Requirements, And Shortens The Go- Live Time

Neonstone's onboarding process involves a thorough understanding of the project's scope, the study in question, and its unique requirements, including the identification and mitigation of potential challenges. Unlike a typical provider that offers a one-size-fits-all solution, Neonstone adopts a highly collaborative client engagement model, where it serves as an extension of clients' teams to truly understand their needs and areas of improvement. This helps the team deliver the best-customized solution that fits their business requirements and project scope.
  • While We're A Software Development Firm, We're Not Software-First. Rather, We Embrace A True Customer-Centric Approach To Understand The Problems And Needs And Then Develop Solutions Tailored To Their Culture And Business Model


It prioritizes open communications with study teams, where a group of developers directly gets involved in client conversations. This approach allows software development teams to comprehend their needs better, enhancing product development excellence and making the engagement more fruitful. Neonstone's powerful approach at its core has enabled it to provide invaluable support to various CROs, pharmaceutical companies, and academic research institutions. The clientele also includes multiple repeat customers, testifying to its excellence in addressing client needs and helping them head toward success.

Neonstone's dedication to streamlining the study processes has positioned it as the life sciences industry's preferred partner for successfully managing clinical trials.

Top 5 Clinical Trial Services Companies in UK – 2023
Current Issue

Company : NEONSTONE

Management
Gareth Hughes, Director

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/neonstone